Spectral AI, Inc. (NASDAQ: MDAI) reported 2025 results on March 24 th after the market close. Highlights since the company’s third quarter release include the elevation of Vincent Capone to Chief ...

Spectral AI Inc. (NASDAQ:MDAI) revealed Monday the performance results of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI, which focuses on medical ...

Spectral AI, Inc. (NASDAQ:MDAI) reported third quarter earnings results on November 11 th. Highlights since our previous update include several presentations at the European Burns Association Congress ...

DALLAS, July 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...

DALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...

Spectral AI, a Dallas-based company specializing in predictive AI for medical diagnostics, has announced the installation of three DeepView® System devices in Australia, following the Australian ...

DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and ...

Spectral AI, Inc. (NASDAQ:MDAI) is one of the most popular AI penny stocks to buy according to billionaires. On June 30, Spectral AI (NASDAQ:MDAI) submitted a De Novo 510k application to the FDA for ...

Last week, Spectral AI, Inc. (NASDAQ:MDAI) announced the submission of its De Novo 510(k) marketing clearance application to the FDA for the DeepView system in burn diagnosis. The submission includes ...